<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>LACTATED RINGERS- sodium chloride, sodium lactate, potassium chloride and calcium chloride injection, solution </strong><br>Baxter Healthcare Corporation<br></p></div>
<h1>Lactated Ringer’s Injection, USP<br>in VIAFLEX Plastic Container</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="i4i_description_id_inv-64601724-ad92-4ff0-8bfb-6da906dc23d3"></a><a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Lactated Ringer’s Injection, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for intravenous administration. It contains no antimicrobial agents. Composition, osmolarity, pH, ionic concentration and caloric content are shown in Table 1.</p>
<a name="id_2be2bdd9-1910-44e3-8717-9b3b2177d657"></a><table border="1" width="855">
<caption><span>Table 1</span></caption>
<col align="left" width="7.0%">
<col align="left" width="4.7%">
<col align="left" width="6.3%">
<col align="left" width="7.7%">
<col align="left" width="7.0%">
<col align="left" width="8.3%">
<col align="left" width="8.3%">
<col align="left" width="10.9%">
<col align="left" width="6.4%">
<col align="left" width="7.0%">
<col align="left" width="6.4%">
<col align="left" width="6.4%">
<col align="left" width="6.4%">
<col align="left" width="7.0%">
<tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule" align="center" rowspan="2" valign="middle"></td>
<td class="Botrule Rrule" align="center" rowspan="2" valign="middle"> Size (mL) </td>
<td class="Botrule Rrule" align="center" colspan="4" valign="middle"> Composition (g/L) </td>
<td class="Botrule Rrule" align="center" rowspan="2" valign="middle"> Osmolarity (mOsmol/L) (calc) </td>
<td class="Botrule Rrule" align="center" rowspan="2" valign="top">
<br><br>pH </td>
<td class="Botrule Rrule" align="center" colspan="5" valign="top"> Ionic Composition (mEq/L) </td>
<td class="Botrule Rrule" align="center" rowspan="2" valign="middle"> Caloric Content (kcal/L) </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="center" valign="middle">Sodium Chloride, USP, (NaCl)</td>
<td class="Botrule Rrule" align="center" valign="middle">Sodium Lactate,<br>(C<span class="Sub">3</span>H<span class="Sub">5</span>NaO<span class="Sub">3</span>)</td>
<td class="Botrule Rrule" align="center" valign="middle">Potassium Chloride, USP, (KCl)</td>
<td class="Botrule Rrule" align="center" valign="middle">Calcium Chloride, USP<br>(CaCl<span class="Sub">2</span>·2H<span class="Sub">2</span>O)</td>
<td class="Botrule Rrule" align="center" valign="top">
<br>Sodium</td>
<td class="Botrule Rrule" align="center" valign="top"><span class="Bold"><br>Potassium</span></td>
<td class="Botrule Rrule" align="center" valign="top">
<br>Calcium</td>
<td class="Botrule Rrule" align="center" valign="top">
<br>Chloride</td>
<td class="Botrule Rrule" align="center" valign="top">
<br>Lactate</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule" align="left" rowspan="3" valign="middle"> Lactated Ringer’s Injection, USP </td>
<td class="Botrule Rrule" align="center" valign="middle"> 250 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 6 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 3.1 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 0.3 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 0.2 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 273 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="top">
<br>6.5 <br>(6.0 to 7.5) </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 130 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"><span class="Bold">4</span></td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 2.7 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 109 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 28 </td>
<td class="Botrule Rrule" align="center" rowspan="3" valign="middle"> 9 </td>
</tr>
<tr><td class="Botrule Lrule Rrule" align="center" valign="middle">500</td></tr>
<tr class="Last"><td class="Botrule Lrule Rrule" align="center" valign="middle">1000</td></tr>
</tbody>
</table>
<p>The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container can leach out certain of its chemical components in very small amounts within the expiration period, e.g., di-2-ethylhexyl phthalate (DEHP), up to 5 parts per million. However, the safety of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="i4i_clinical_pharmacology_id_inv-bf9470bc-ddfe-4d62-bcd4-32c414bfe94c"></a><a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">Lactated Ringer’s Injection, USP has value as a source of water and electrolytes. It is capable of inducing <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">diuresis</span> depending on the clinical condition of the patient.</p>
<p>Lactated Ringer’s Injection, USP produces a metabolic alkalinizing effect. Lactate ions are metabolized ultimately to <span class="product-label-link" type="condition" conceptid="4135927" conceptname="Carbon dioxide">carbon dioxide</span> and water, which requires the consumption of hydrogen cations.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="i4i_indications_id_inv-95686bda-6a10-4b07-be20-56b1a18e594c"></a><a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Lactated Ringer’s Injection, USP is indicated as a source of water and electrolytes or as an alkalinizing agent.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="i4i_contraindications_id_inv-13ff7959-b07d-421d-b49e-a8c733db6f08"></a><a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">As for other calcium-containing infusion solutions, concomitant administration of ceftriaxone and Lactated Ringer’s Injection, USP is contraindicated in newborns (≤ 28 days of age), even if separate infusion lines are used (risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream). </p>
<p>In patients older than 28 days (including adults), ceftriaxone must not be administered simultaneously with intravenous calcium-containing solutions, including Lactated Ringer’s Injection, USP, through the same infusion line (e.g., via Y-connector).  <br>If the same infusion line is used for sequential administration, the line must be thoroughly <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushed</span> between infusions with a compatible fluid. </p>
<p>Lactated Ringer’s Injection, USP is contraindicated in patients with a known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to sodium lactate.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="i4i_warnings_id_inv-3702da0b-318a-4a06-a170-8fd1379df18c"></a><a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">Although Lactated Ringer’s Injection, USP has a potassium concentration similar to the concentration in plasma, it is insufficient to produce a useful effect in case of severe <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">potassium deficiency</span>; therefore, it should not be used for this purpose.</p>
<p>Lactated Ringer’s Injection, USP is not for use  for the treatment of <span class="product-label-link" type="condition" conceptid="4239233" conceptname="Lactic acidosis">lactic acidosis</span> or severe <span class="product-label-link" type="condition" conceptid="4245042" conceptname="Metabolic acidosis">metabolic acidosis</span>.</p>
<p>Lactated Ringer’s Injection, USP should not be administered simultaneously with citrate anticoagulated/preserved blood through the same administration set because of the likelihood of coagulation.</p>
<p>The infusion must be stopped immediately if any signs or symptoms of a suspected <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> develop.  Appropriate therapeutic countermeasures must be instituted as clinically indicated.  <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span> are reported more frequently during pregnancy.</p>
<p>Depending on the volume and the rate of infusion, the intravenous administration of Lactated Ringer’s Injection, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, congested states,  <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> or acid-base imbalance. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and <span class="product-label-link" type="condition" conceptid="4078925" conceptname="Pulmonary edema">pulmonary edema</span> is directly proportional to the electrolyte concentrations of the injections.</p>
<p>Clinical evaluation and periodic laboratory determinations may be necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient or the rate of administration warrants such evaluation.</p>
<p>Lactated Ringer’s Injection, USP should be administered with particular caution, if at all, to patients with <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> or conditions predisposing to <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> (such as severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> or adrenocortical insufficiency, acute <span class="product-label-link" type="condition" conceptid="435796" conceptname="Dehydration">dehydration</span>, or extensive tissue injury or <span class="product-label-link" type="condition" conceptid="4022094" conceptname="Thermal burn">burns</span>) and in patients with cardiac disease. </p>
<p>Lactated Ringer’s Injection, USP should be administered with particular caution, if at all, to patients with <span class="product-label-link" type="condition" conceptid="438730" conceptname="Alkalosis">alkalosis</span> or at risk for <span class="product-label-link" type="condition" conceptid="438730" conceptname="Alkalosis">alkalosis</span>.  Because lactate is metabolized to <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>, administration may result in, or worsen, <span class="product-label-link" type="condition" conceptid="4030381" conceptname="Metabolic alkalosis">metabolic alkalosis</span>. </p>
<p>Lactated Ringer’s Injection, USP should be administered with particular caution, if at all, to patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>, <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">hypervolemia</span>, <span class="product-label-link" type="condition" conceptid="4266976" conceptname="Overhydration">overhydration</span>, or conditions that may cause sodium and/or potassium retention, <span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">fluid overload</span>, or <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="i4i_precautions_id_inv-00993beb-0ad0-4d27-bc6b-1e2e1ef9177b"></a><a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Do not connect flexible plastic containers in series in order to avoid <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> due to possible residual air contained in the primary container.</p>
<p>Pressurizing intravenous solutions contained in flexible plastic containers to increase flow rates can result in <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span> if the residual air in the container is not fully evacuated prior to administration.  </p>
<p>Use of a vented intravenous administration set with the vent in the open position could result in <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">air embolism</span>.  Vented intravenous administration sets with the vent in the open position should not be used with flexible plastic containers.</p>
<p>Lactated Ringer’s Injection, USP should be administered with particular caution, if at all, to patients with conditions associated with increased lactate levels or impaired lactate utilization, such as severe <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic insufficiency</span>.  </p>
<p>Hyperlactatemia can develop in patients with severe <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic insufficiency</span>, since lactate metabolism may be impaired.  In addition Lactated Ringer’s Injection, USP may not produce its alkalinizing action in patients with severe <span class="product-label-link" type="condition" conceptid="4245975" conceptname="Hepatic failure">hepatic insufficiency</span>, since lactate metabolism may be impaired. </p>
<p>Solutions containing calcium salts should be used with caution in patients with <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span> or conditions predisposing to hypercalemia, such as patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span> and granulomatous diseases associated with increased calcitriol synthesis such as <span class="product-label-link" type="condition" conceptid="438688" conceptname="Sarcoidosis">sarcoidosis</span>, calcium <span class="product-label-link" type="condition" conceptid="201620" conceptname="Kidney stone">renal calculi</span> or history of such calculi. </p>
<p>Lactate is a substrate for gluconeogenesis. This should be taken into account when Lactated Ringer’s Injection, USP is used in patients with type 2 <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>.</p>
<div class="Section" data-sectionCode="34081-0">
<a name="i4i_pediatric_use_id_inv-95f79c5c-2778-4c0e-8063-78243b2e0f10"></a><a name="section-6.1"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness of Lactated Ringer’s Injection, USP in pediatric patients have not been established by adequate and well controlled trials, however, the use of electrolyte solutions in the pediatric population is referenced in the medical literature. The warnings, precautions and adverse reactions identified in the label copy should be observed in the pediatric population.</p>
<p>Lactate-containing solutions should be administered with particular caution to neonates and infants less than 6 months of age.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="i4i_geriatric_use_id_inv-2fc20330-7a7e-41c7-9942-b4bfb2637693"></a><a name="section-6.2"></a><p></p>
<h2>Geriatric Use</h2>
<p class="First">Clinical studies of Lactated Ringer’s Injection, USP did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="i4i_drug_interaction_id_4e589f69-5545-4e5b-a50d-d6ed85976e93"></a><a name="section-6.3"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Ceftriaxone – see <a href="#i4i_contraindications_id_inv-13ff7959-b07d-421d-b49e-a8c733db6f08">CONTRAINDICATIONS</a></p>
<p>Caution is advised when administering Lactated Ringer’s Injection, USP to patients treated with drugs that may increase the risk of sodium and <span class="product-label-link" type="condition" conceptid="4125002" conceptname="Idiopathic fluid retention">fluid retention</span>, such as corticosteroids. </p>
<p>Caution is advised when administering Lactated Ringer’s Injection, USP to patients treated with drugs for which renal elimination is pH dependent.  Due to the alkalinizing action of lactate (formation of <span class="product-label-link" type="condition" conceptid="4285456" conceptname="Bicarbonate">bicarbonate</span>), Lactated Ringer’s Injection, USP may interfere with the elimination of such drugs.</p>
<ul>
<li>Renal clearance of acidic drugs such as salicylates and barbiturates may be increased.</li>
<li>Renal clearance of alkaline drugs, such as sympathomimetics (e.g., ephedrine, pseudoephedrine) and dextroamphetamine (dexamphetamine) sulfate, may be decreased. <p class="First"></p>
</li>
</ul>
<p>Renal clearance of lithium may also be increased.  Caution is advised when administering Lactated Ringer’s Injection, USP to patients treated with lithium.</p>
<p>Because of its potassium content, Lactated Ringer’s Injection, USP should be administered with caution in patients treated with agents or products that can cause <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span> or increase risk of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, such as potassium sparing diuretics (amiloride, spironolactone, triamterene), with ACE inhibitors, angiotensin II receptor antagonists, or the immunosuppressants tacrolimus and cyclosporine.  </p>
<p>Caution is advised when administering Lactated Ringer’s Injection, USP to patients treated with thiazide diuretics or vitamin D, as these can increase the risk of <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="i4i_pregnancy_id_inv-5c253037-3169-4f57-854f-86bf27211875"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="i4i_teratogenic_id_inv-65aeaa78-4b40-4c0f-8984-532885fc29db"></a><a name="section-6.4.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_pregnancy_C_id_83f0d954-954a-41eb-85ba-612323e5ae6a"></a><a name="section-6.4.1.1"></a><p></p>
<h4>Pregnancy Category C.</h4>
<p class="First">Animal reproduction studies have not been conducted with Lactated Ringer’s Injection, USP. It is also not known whether Lactated Ringer’s Injection, USP can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Lactated Ringer’s Injection, USP should be given to a pregnant woman only if clearly needed.</p>
<p>For <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity Reactions</span> During Pregnancy – see <a href="#i4i_warnings_id_inv-3702da0b-318a-4a06-a170-8fd1379df18c">WARNINGS</a></p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="i4i_carcinogenesis_mutagenesis_fertility_id_b59b4746-99eb-4102-aee7-aa7a6a617780"></a><a name="section-6.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility</h2>
<p class="First">Long-term studies in animals to evaluate carcinogenic potential or studies to evaluate mutagenic potential have not been performed with  Lactated Ringer’s Injection, USP.  Studies to evaluate the possible impairment of fertility have not been performed.</p>
</div>
<div class="Section" data-sectionCode="34079-4">
<a name="i4i_labour_delivery_id_7b1ff7fe-be04-48c0-8af3-5ba51935709f"></a><a name="section-6.6"></a><p></p>
<h2>Labor and Delivery</h2>
<p class="First">Studies have not been conducted to evaluate the effects of Lactated Ringer’s Injection, USP on labor and delivery. Caution should be exercised when administering this drug during labor and delivery.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="i4i_nursing_mothers_id_76dc6436-a69a-42ad-aee4-df3306a8e5b1"></a><a name="section-6.7"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Lactated Ringer’s Injection, USP is administered to a nursing mother.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="i4i_adverse_effects_id_inv-0938fd63-b672-4596-8cb9-abcbef8b4aae"></a><a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_29efd26d-9797-4544-a1de-b05910e9f5a5"></a><a name="section-7.1"></a><p></p>
<h2>Post-Marketing Adverse Reactions</h2>
<p class="First">The following adverse reactions have been reported in the post-marketing experience, listed by MedDRA System Organ Class (SOC).</p>
<p><span class="product-label-link" type="condition" conceptid="440371" conceptname="Disorder of immune function">Immune System Disorders</span>:  <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity</span>/infusion reactions, including anaphylactic/<span class="product-label-link" type="condition" conceptid="4148381" conceptname="Anaphylactoid reaction">anaphylactoid reactions</span>, and the following manifestations: <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">chest pain</span>, <span class="product-label-link" type="condition" conceptid="4133044" conceptname="Chest discomfort">chest discomfort</span>, decreased heart rate, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="314171" conceptname="Low blood pressure reading">blood pressure decreased</span>, <span class="product-label-link" type="condition" conceptid="4158346" conceptname="Respiratory distress">respiratory distress</span>, <span class="product-label-link" type="condition" conceptid="256717" conceptname="Bronchospasm">bronchospasm</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="254761" conceptname="Cough">cough</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="318566" conceptname="Flushing">flushing</span>, <span class="product-label-link" type="condition" conceptid="4038048" conceptname="Throat irritation">throat irritation</span>, <span class="product-label-link" type="condition" conceptid="4193492" conceptname="Acroparesthesia">paresthesias</span>, <span class="product-label-link" type="condition" conceptid="4009388" conceptname="Perioral numbness">hypoesthesia oral</span>, <span class="product-label-link" type="condition" conceptid="436235" conceptname="Taste sense altered">dysgeusia</span>, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="437663" conceptname="Fever">pyrexia</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span></p>
<p>Metabolism and Nutrition Disorders: <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">Hyperkalemia</span></p>
<p>General Disorders and Administration Site Conditions:<br>Infusion site reactions, including <span class="product-label-link" type="condition" conceptid="318174" conceptname="Phlebitis">phlebitis</span>, infusion site <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span>, infusion site <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, infusion site <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, infusion site <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, infusion site <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, infusion site <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">pain</span>, infusion site burning</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_37681fd2-2e2e-4dca-be63-c3e338e4aebc"></a><a name="section-7.2"></a><p></p>
<h2>Class Reactions</h2>
<p class="First"><span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">Hypersensitivity reactions</span>, including, <span class="product-label-link" type="condition" conceptid="22350" conceptname="Edema of larynx">laryngeal edema</span> and <span class="product-label-link" type="condition" conceptid="4328356" conceptname="Sneezing">sneezing</span></p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_3a8bbbbb-a3e7-46c4-9ddb-c235aa6dd2ce"></a><a name="section-7.2.1"></a><p></p>
<h3><span class="product-label-link" type="condition" conceptid="434004" conceptname="Hypervolemia">Hypervolemia</span></h3>
<p class="First">Infusion site reactions, including <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">Infection</span> at the site of injection, <span class="product-label-link" type="condition" conceptid="4295895" conceptname="Extravasation">extravasation</span>, and infusion site anesthesia (<span class="product-label-link" type="condition" conceptid="4151171" conceptname="Numbness of limbs">numbness</span>)</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="i4i_overdosage_id_4fa15318-1796-41e1-8acd-20c4ae754042"></a><a name="section-7.3"></a><p></p>
<h2><span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">Overdose</span></h2>
<p class="First">An excessive volume or too high a rate of administration of Lactated Ringer’s Injection, USP may lead to fluid and sodium overload with a risk of <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> (peripheral and/or pulmonary), particularly when renal sodium excretion is impaired. </p>
<p>Excessive administration of lactate may lead to <span class="product-label-link" type="condition" conceptid="4030381" conceptname="Metabolic alkalosis">metabolic alkalosis</span>.  <span class="product-label-link" type="condition" conceptid="4030381" conceptname="Metabolic alkalosis">Metabolic alkalosis</span> may be accompanied by <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>.</p>
<p>Excessive administration of potassium may lead to the development of <span class="product-label-link" type="condition" conceptid="434610" conceptname="Hyperkalemia">hyperkalemia</span>, especially in patients with severe <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">renal impairment</span>.</p>
<p>Excessive administration of calcium salts may lead to <span class="product-label-link" type="condition" conceptid="435511" conceptname="Hypercalcemia">hypercalcemia</span>.</p>
<p>When assessing an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span>, any additives in the solution must also be considered.</p>
<p>The effects of an <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdose</span> may require immediate medical attention and treatment.</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="i4i_dosage_admin_id_inv-ac2c45fe-f973-402a-8bad-3fd52b802b62"></a><a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">As directed by a physician. Dosage, rate and duration of administration are to be individualized and dependent upon the indication for use, the patient’s age, weight, concomitant treatment and clinical condition of the patient as well as laboratory determinations.</p>
<p>All injections in VIAFLEX plastic containers are intended for intravenous administration using sterile and nonpyrogenic equipment.</p>
<p>After opening the container, the contents should be used immediately and should not be stored for a subsequent infusion.  Do not reconnect any partially used containers.</p>
<p>Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not administer unless the  solution is clear and seal is intact.</p>
<p>When making additions to Lactated Ringer’s Injection, USP, aseptic technique must be used.  Mix the solution thoroughly when additives have been introduced.  Do not store solutions containing additives. </p>
<p>Additives may be incompatible with Lactated Ringer’s Injection, USP.  As with all parenteral solutions, compatibility of the additives with the solution must be assessed before addition, by checking for a possible color change and/or the appearance of precipitates, insoluble complexes, or crystals.  Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Lactated Ringer’s Injection, USP is appropriate. </p>
<p>The instructions for use of the medication to be added and other relevant literature must be consulted.  Additives known or determined to be incompatible should not be used.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="i4i_how_supplied_id_inv-46eb48fd-8f18-47a7-8dd8-31b3b3ba7c1e"></a><a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">Lactated Ringer’s Injection, USP in VIAFLEX plastic container is available as follows:</p>
<a name="id_1b7620d0-cf33-49bd-a5e1-528a0d541db2"></a><table width="500">
<col align="left" width="28.0%">
<col align="left" width="28.0%">
<col align="left" width="44.0%">
<tbody class="Headless">
<tr class="First">
<td class="Toprule" align="left" valign="middle"><span class="Bold">Code</span></td>
<td class="Toprule" align="left" valign="middle"><span class="Bold">Size (mL)</span></td>
<td align="left" valign="middle"><span class="Bold">NDC</span></td>
</tr>
<tr>
<td align="left" valign="middle"> 2B2322 </td>
<td align="left" valign="middle"> 250 </td>
<td align="left" valign="middle"> 0338-0117-02 </td>
</tr>
<tr>
<td align="left" valign="middle"> 2B2323 </td>
<td align="left" valign="middle"> 500 </td>
<td align="left" valign="middle"> 0338-0117-03 </td>
</tr>
<tr class="Last">
<td class="Botrule" align="left" valign="middle"> 2B2324 </td>
<td class="Botrule" align="left" valign="middle"> 1000 </td>
<td class="Botrule" align="left" valign="middle"> 0338-0117-04 </td>
</tr>
</tbody>
</table>
<p>Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C); brief exposure up to 40°C does not adversely affect the product.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-e15b3991-7871-4593-b9b3-72307b886bb3"></a><a name="section-10"></a><p></p>
<h1>DIRECTIONS FOR USE OF VIAFLEX PLASTIC CONTAINER</h1>
<p class="First">For Information on Risk of <span class="product-label-link" type="condition" conceptid="4156949" conceptname="Air embolism">Air Embolism</span> – see <a href="#i4i_precautions_id_inv-00993beb-0ad0-4d27-bc6b-1e2e1ef9177b">PRECAUTIONS</a></p>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-cec397a3-6600-4ef4-a1b6-86b0df19f0a0"></a><a name="section-10.1"></a><p></p>
<h2>To Open</h2>
<p class="First">Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the outlet port protector is damaged, <span class="product-label-link" type="condition" conceptid="4071366" conceptname="Indifference">detached</span>, or not present, discard container as solution path <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span> may be impaired. If supplemental medication is desired, follow directions below.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-dbf612db-3c3c-479b-8de6-c948187a2cae"></a><a name="section-10.2"></a><p></p>
<h2>Preparation for Administration</h2>
<ol>
<li>Suspend container from eyelet support.</li>
<li>Remove protector from outlet port at bottom of container.</li>
<li>Attach administration set. Refer to complete directions accompanying set.</li>
</ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_inv-d895c3fe-e6b2-4b4b-98f4-3a84c5adb538"></a><a name="section-10.3"></a><p></p>
<h2>To Add Medication</h2>
<p class="First"><span class="Bold">To add medication before solution administration</span></p>
<ol>
<li>Prepare medication site.</li>
<li>Using syringe with 19 to 22 gauge needle, puncture medication port and inject.</li>
<li>Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.</li>
</ol>
<p><span class="Bold">To add medication during solution administration</span></p>
<ol>
<li>Close clamp on the set.</li>
<li>Prepare medication site.</li>
<li>Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.</li>
<li>Remove container from IV pole and/or turn to an upright position.</li>
<li>Evacuate both ports by squeezing them while container is in the upright position.</li>
<li>Mix solution and medication thoroughly.</li>
<li>Return container to in use position and continue administration.</li>
</ol>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="i4i_section_id_8d5dcc0a-93c5-4b74-87a3-c40fbe0fc7c6"></a><a name="section-11"></a><p></p>
<p class="First"><span class="Bold">Baxter Healthcare Corporation</span><br>Deerfield, IL 60015 USA</p>
<p>Printed in USA</p>
<p><span class="Bold">07-19-72-479</span></p>
<p><span class="Bold">Rev. November 2013</span></p>
<p>BAXTER, VIAFLEX, and PL 146 are trademarks of Baxter International Inc.</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="i4i_Principal_display_panel_id_f3fdeba6-24c0-43a4-9803-828e8ca4280c"></a><a name="section-12"></a><p></p>
<h1>PACKAGE LABELING - PRINCIPAL DISPLAY PANEL</h1>
<p class="First"> </p>
<div class="Figure">
<img alt="Lactated Ringers Representative container label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dad7735c-709b-40ea-ab7a-15577e24a966&amp;name=89be82de-4d68-4449-8da5-21e5dda26d13-01.jpg"><p class="MultiMediaCaption">Container Label</p>
</div>
<p>LOT</p>
<p>EXP</p>
<p><span class="Bold">2B2322</span></p>
<p><span class="Bold">NDC 0338-0117-02</span></p>
<p><span class="Bold"><span class="Bold">Lactated Ringer’s<br>Injection USP</span></span></p>
<p><span class="Bold">250 mL </span></p>
<p>Each100 mL contains<br>600 mg Sodium<br>Chloride USP 310 mg Sodium Lactate<br>30 mg Potassium Chloride USP 20 mg<br>Calcium Chloride USP pH 6.5 (6.0 to<br>7.5) mEq/L Sodium 130 Potassium 4<br>Calcium 2.7 Chloride 109 Lactate 28<br>Osmolarity 273 mOsmol/L (calc)<br>Sterile Nonpyrogenic Single dose<br>container <span class="Bold">Not for use in the treatment<br>of <span class="product-label-link" type="condition" conceptid="4239233" conceptname="Lactic acidosis">lactic acidosis</span></span> Additives may be<br>incompatible Consult with pharmacist<br>if available When introducing additives<br>use aseptic technique Mix thoroughly<br>Do not store Dosage Intravenously as<br>directed by a physician See directions<br>Cautions Squeeze and inspect inner<br>bag which maintains product <span class="product-label-link" type="condition" conceptid="4035976" conceptname="Sterility">sterility</span><br>Discard if leaks are found Must not be</p>
<p>used in series connections Do not<br>administer simultaneously with blood<br>Do not use unless solution is clear Rx<br>Only Store unit in moisture barrier<br>overwrap at room temperature<br>(25°C/77°F) until ready to use Avoid<br>excessive heat See insert</p>
<p>Viaflex container<br>PL 146 plastic</p>
<p>BAXTER Viaflex and PL 146 are trademarks of Baxter International Inc</p>
<p><span class="Bold"><span class="Italics">Baxter</span></span><br>Baxter Healthcare Corporation<br>DeerfieldIL60015 USA</p>
<p>Made in USA</p>
<p>For product information<br>1-800-933-0303</p>
<div class="Figure">
<img alt="Lactated Ringer's Representative carton label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=dad7735c-709b-40ea-ab7a-15577e24a966&amp;name=89be82de-4d68-4449-8da5-21e5dda26d13-02.jpg"><p class="MultiMediaCaption">Carton Label</p>
</div>
<p>FOR HI-RES INK JET: </p>
<p>2B2322Q <br>36-250 ML </p>
<p>VIAFLEX® CONTAINER <br>LACTATED RINGER’S INJECTION, USP </p>
<p>EXP </p>
<p>XXXXX </p>
<p>SECONDARY BAR CODE <br>(17) YYMM00 (10) XXXXX </p>
<p>LOT </p>
<p>XXXXX </p>
<p>PRIMARY BAR CODE </p>
<p>(01)50303380117029 </p>
<br><p>2B2B2322Q 2B2322QQ </p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>LACTATED RINGERS 		
					</strong><br><span class="contentTableReg">sodium chloride, potassium chloride, sodium lactate and calcium chloride injection, solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:0338-0117</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">INTRAVENOUS</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>SODIUM CHLORIDE</strong> (SODIUM CATION and CHLORIDE ION) </td>
<td class="formItem">SODIUM CHLORIDE</td>
<td class="formItem">600 mg  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>SODIUM LACTATE</strong> (SODIUM CATION and LACTIC ACID) </td>
<td class="formItem">SODIUM LACTATE</td>
<td class="formItem">310 mg  in 100 mL</td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>POTASSIUM CHLORIDE</strong> (POTASSIUM CATION and CHLORIDE ION) </td>
<td class="formItem">POTASSIUM CHLORIDE</td>
<td class="formItem">30 mg  in 100 mL</td>
</tr>
<tr class="formTableRow">
<td class="formItem">
<strong>CALCIUM CHLORIDE</strong> (CALCIUM CATION and CHLORIDE ION) </td>
<td class="formItem">CALCIUM CHLORIDE</td>
<td class="formItem">20 mg  in 100 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:0338-0117-02</td>
<td class="formItem">250 mL in 1 BAG</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:0338-0117-03</td>
<td class="formItem">500 mL in 1 BAG</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">3</th>
<td class="formItem">NDC:0338-0117-04</td>
<td class="formItem">1000 mL in 1 BAG</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA016682</td>
<td class="formItem">03/22/1971</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Baxter Healthcare Corporation
							(005083209)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Baxter Healthcare Corporation</td>
<td class="formItem"></td>
<td class="formItem">059140764</td>
<td class="formItem">ANALYSIS(0338-0117), MANUFACTURE(0338-0117), LABEL(0338-0117), PACK(0338-0117), STERILIZE(0338-0117)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 4/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>89be82de-4d68-4449-8da5-21e5dda26d13</div>
<div>Set id: dad7735c-709b-40ea-ab7a-15577e24a966</div>
<div>Version: 3</div>
<div>Effective Time: 20140411</div>
</div>
</div> <div class="DistributorName">Baxter Healthcare Corporation</div></p>
</body></html>
